Referencias bibliográficas con respecto a glicina

1. Zhong Z, Enomoto N, Connor HD, Moss N, Mason RP y

Thurman RG: Glycine improves survival after hemorrhagic

shock in the rat. Shock, 1999, 12:54-62.

2. Serrano L, Neira JL, Sancho J y cols.: Effect of alanine versus

glycine in á-helices on protein stability. Nature, 1992,


3. Steinert PM, Mack JW, Korge BP et al.: Glycine loops in pro-

teins: Their occurrence in certain intermediate filament

chains, loricrins and single-stranded RNA binding proteins.

Int J Biol Macromol, 1991, 13:130-139.

4. Mackay K, Raghunath M, Superti-Furga A y cols.: Ehlers-

Danlos syndrome type IV caused by Gly400Glu, Gly595Cys

and Gly100Asp substitutions in collagen III: clinical features,

biochemical screening and molecular confirmation. Clin Ge-

net, 1996, 49:286-295.

5. Yang W, Battineni ML y Brodsky B: Amino acid sequence

environment modulates the disruption by osteogenesis imper-

fecta glycine substitutions in collagen-like peptide. Bioche-

mistry, 1997, 36:6930-6945.

6. Lee JY, Pulkkinen L, Liu HS y cols.: A glycine-to-arginine

substitution in the triple-helical domain of type VII collagen

in a family with dominant dystrophic epidermolysis bullosa

pruriginosa. J Invest Dermatol, 1997, 108:947-949.

7. Malwal Y, Paradis K y Qureshi IA: Developmental profile of

mitochondrial glycine N-acytransferase in human liver. J Pe-

diatr, 1997, 130:1003-1007.

8. Amelsberg A, Schteingart CD, Ton-Un HT y cols.: Carrier-

medicated jejunal absortion of conjugated bile acids in the

guinea pig. Gastroenterology, 1996, 110:1098-1106.

9. Seva C, Dickinson CJ y Yamada T: Growth-promoting effects

of glycine-extended progastrin. Science, 1994, 265:410-412.

10. Milgram SL, Kho ST, Martin GV y cols.: Localization of inte-

gral membrane peptidylglycine alpha-amidating monooxyge-

nase in neuroendocrine cells. J Cell Sci, 1997, 110:695-706.

11. Kunin CM, Hua TH, Van Arsdale White L y cols.: Growth of

Escherichia coli in human urine: Role of salt tolerance and accu-

mulation of glycine betaine. J Infect Dis, 1992, 166:1311-1315.

12. Laniado ME, Abel PD y Lelani EN: Ion channels: New expla-

nations for old diseases. Br Med J, 1997, 315:1171-1172.

13. Jentsch TJ y Gunther W: Cloride channels: An emerging mo-

lecular picture. Bioessays, 1997, 19:117-126.

14. Ortells MO y Lunt GG: Evolutionary history of the ligand-ga-

ted ion-channel superfamily of receptors. Trends Neurosci,

1995, 18:121-127.

15. RaJendra S, Lynch JW, Schofield PR: The glycine receptor.

Pharmacol Ther, 1997, 73:121-146.

16. Kuhse J, Betz H y Kirsch J: The inhibitory glycine receptor:

Architecture, Synaptic localization and molecular pathology

of a postsynaptic ion-channel complex. Curr Opin Neurobiol,

1995, 5:318-323.

17. Simpson RK Jr, Robertson CS y Goodman JC: Glycine: An

important potential component of spinal shock. Neurochem

Res, 1993, 18:887-892.

18. Araki T, Ito M y Oscarsson O: Anion permeability of the sy-

naptic and non-synaptic motoneurone membrane. J Physiol,

1961, 159:410-435.

19. Aprison MH y Werman R: The distribution of glycine in cat

spinal cord and roots. Life Sci, 1965, 4:2075-2083.

20. Davidoff RA, Graham LT Jr, Shank RP, Werman R y Aprison

MH: Changes in amino acid concentrations associated with loss

of spinal interneurons. J Neurochem, 1967, 14:1025-1031.

21. Hokfelt T y Ljungdahl A: Light and electron microscopic au-

toradiograph on spinal cord slices after incubation with labe-

led glycine. Brain Res, 1971, 32:189-194.

22. Werman R, Davidoff RA y Aprison MH: Inhibition of motoneu-

rons by ionophoresis of glycine. Nature, 1967, 214:681-683.

23. Curtis DR, Hosli L, Johnston GAR y Johnston IH: The hiper-

polerization of spinal motoneurones by glycine and related

amino acids. Exp Brain Res, 1968, 5:235-258.

24. Curtis DR, Hosli L y Johnston GAR: A pharmacological

study of the depression of spinal neurones by glycine and rela-

ted amino acids. Exp Brain Res, 1968, 6:1-18.

25. Curtis DR: The depression of spinal inhibition by electropho-

retically administered strychnine. Int J Neuropharmacol,

1962, 1:239-250.

26. Young AB y Snyder SH. Strychnine binding associated with

glycine receptors of the central nervous system. Proc Natl

Acad Sci USA, 1973, 70:2832-2836.

27. Ikejima K, Qu W, Stachlewitz RF y Thurman RG: Kupffer

cells contain a glycine-gated chloride channel. Am J Physiol,

1997, 272:G1581-G1586.

28. Stachlewitz RF, Ikejima K y Thurman RG: Increases in intra-

cellular calcium in neutrophils (PMNs) due to formyl-methio-

nine-leucine-phenylalanine (FMLP) and endotoxin are bloc-

ked completely by glycine. Hepatology, 1995, 22:1105.

29. Pfeiffer F y Betz H: Solubilization of the glycine receptor

from the rat spinal cord. Brain Res, 1981, 226:273-279.

30. Pfeiffer F, Graham D y Betz H: Purification by affinity chro-

motography of the glycine receptor of rat spinal cord. J Biol

Chem, 1982, 257:9389-9393.

31. Pfeiffer F, Simler R, Grenningloh G y Betz H: Monoclonal

antibodies and peptide mapping reveal structural similarities

between the subunits of the glycine receptor of rat spinal

chord. Proc Natl Acad Sci USA, 1984, 81:7224-7227.

32. Grenningloh G, Schmieden V, Schofield PR y cols.: Alpha su-

bunit variants of the human glycine receptor: primary structu-

res, functional expression, and chromosomal localization of

the corresponding genes. EMBO J, 1990, 9:771-779.

33. Handford CA, Lynch JW, Baker E y cols.: The human glycine

receptor beta subunit: primary structure, functional characteri-

zation and chromosomal localization of the human and murine

genes. Brain Res Mol Brain Res, 1996, 35:211-219.

34. Ryan SG, Buckwalter MS, Lynch JW y cols.: A missense mu-

tation in the gene encoding the alpha 1 subunit of the inhibi-

tory glycine receptor in the spasmodic mouse. Nat Genet,

1994, 7:131-135.

35. Saul B, Schmieden V, Kling C y cols.: Point mutation of gly-

cine receptor alpha 1 subunit in spasmatic mouse affects ago-

nist responses. FEBS Lett, 1994, 350:71-76.

36. Kinsmore SF, Giros B, Suh D, Bieniarz M, Caron MG y Sel-

din MF: Glycine receptor beta-subunit gene mutation in spas-

tic mouse associated with LINE-1 element insertion. Nat Ge-

net, 1994, 7:136-141.

37. Matzenbach B, Maulet Y, Sefton L y cols.: Structural analysis

of mouse glycine receptor alpha subunit genes: identification

and chromosomal localization of a noel variant. J Biol Chem,

1994, 269:2607-2612.

38. Wheeler MD, Ikejema K, Enomoto N y cols.: Glycine: a new

anti-inflammatory immunonutrient. Cell Mol Life Sci, 1999,


39. Kurose I, Higuchi H, Kato S y cols.: Oxidative stress on mito-

chondria and cell membrane of cultured rat hepatocytes and

perfused liver exposed to ethanol. Gastroenterology, 1997,


40. Hamano K, Tsuboi H, Seyama A y Esato K: Shock-reinfusion

injury to the central organs and the effect of free radical sca-

vengers in the rat. Surg Today, 1993, 23:891-896.

41. Deters M, Strubelt O y Younes M: Protection by glycine

against hypoxia-reoxygenation induced hepatic injury. Res

Commun Mol Pathol Pharmacol, 1997, 97:199-213.

42. Ikejima K, Iimuro Y, Forman DT y Thurman RG: A diet con-

taining glycine improves survival in endotoxin shock in the

rat. Am J Physiol 1996, 271:97-103.

43. Stachlewitz RF, Seabra V, Bradford B y cols.: Glycine and

uridine prevent D-galactosamine hepatotoxicity in the rat: role

of Kupffer cells. Hepatology, 1999, 29:737-745.

44. Van Den Branden C, Ceyssens B, De Craemer D y cols.: An-

tioxidant enzyme gene expression in rats with remnant kidney

induced chronic renal failure. Exp Nephrol, 2000, 8:91-96.

45. Seneviratne CK, Li T, Khaper N y Signal PK: Effects of met-

hionine on endogenous antioxidants in the heart. Am J Phy-

siol, 1999, 277:2124-2128.

46. Khaper N, Rigatto C, Seneviratne C, Li T y Signal PK: Chro-

nic treatment with propranolol induces antioxidant changes

and protects against ischemia-reperfusion injury. J Mol Cell

Cardiol, 1997, 29:3335-3344.

47. Laskin DL: Nonparenchymal cells and hepatotoxicity. Sem

Liver Dis, 1990, 10:293-304.

48. Goris RJ, Te Boekhorst TP, Nuytinck JK y Gimbrere JS: Mul-

tiple-organ failure. Generalized autodestructive inflamma-

tion? Arch Surg, 1985, 120:1109-1115.

49. Carrico CJ, Meakins JL, Marshall JC, Fry D y Maier RV: Mul-

tiple-organ failure syndrome. Arch Surg, 1986, 121:196-208.

50. Bouwens L: Structural and functional aspects of Kupffer cells.

Revis Biol Celular, 1988, 16:69-94.

51. Jaeschke H y Farhood A: Neutrophil and Kupffer cell-induced

oxidant stress and ischemia-reperfusion injury in rat liver. Am

J Physiol, 1991, 260:355-362.

52. Tamion F, Richard V, Lyoumi S y cols.: Gut ischemia and

menenteric synthesis of inflamatory cytokines after hemorrha-

gic or endotoxic shock. Am J Physiol, 1997, 36:314-321.

53. Tamion F, Richard V, Bonmarchand G y cols.: Reduced synt-

hesis of inflammatory cytokines by a free radical scavenger

after hemorrhagic shock in rats. Crit Care Med, 2000,


54. Toborek M, Barger SW, Mattson MP, Mcclain CJ y Hennig

B: Role of glutathione redox cycle in TNF-alpha mediated en-

dothelial cell dysfunction. Atherioscler Thromb Vasc Biol,

1995, 117:179-188.

55. Adamson GM y Billings RE: Tumor necrosis factor induced

oxidative stress in isolated mouse hepatocytes. Arc Biochem

Biophys, 1992, 294:223-229.

56. Nussler AK, Di Silvio KM, Billiar TR y cols.: Stimulation of

the nitric oxide synthase pathway in human hepatocytes by

cytokines and endotoxin. J Exp Med, 1992, 176:261-264.

57. Robbins RA, Springall DR, Warren JB y cols.: Inducible ni-

tric oxide synthase is increased in murine lung epithelial cells

by cytokine stimulation. Biochem Biophys Res Commun,

1994, 198:835-843.

58. Lee BS, Kang HS, Pyun KH y Choi I: Roles of tyrosine kina-

ses in the regulation of nitric oxide synthesis in murine liver

cells: modulation of NF-kappa B activity by tyrosine kinases.

Hepatology, 1997, 25:913-919.

59. Bautista AP y Spitzer JJ: Inhibition of nitric oxide formation

in vivo enhances superoxide release by the perfused liver. Am

J Physiol, 1994, 266:783-788.

60. Ma TT, Ischiropoulos H y Brass CA: Endotoxin-stimulated

nitric oxide production increases injury and reduces rat liver

chemiluminescence during reperfusion. Gastroenterology,

1995, 108:463-469.

61. Radi R, Beckman JS, Bush KM y Freeman BA: Peroxynitrite

oxidation of sulfhydryls: the cytotoxic potential of superoxide

and nitric oxide. J Biol Chem, 1991, 266:4244-4250.

62. Lipton SA, Choi YB, Pan ZH y cols.: A redox-based mecha-

nism for the neuroprotective and neurodestructive effects of

nitric oxide and related nitroso-compounds. Nature, 1993,


63. Kooy NW, Royall JA, Ye YZ, Kelly DR y Beckman JS: Evi-

dence for in vivo peroxynitrite production in human acute lung

injury. Am J Respir Crit Care Med, 1995, 151:1250-1254.

64. Minnard EA, Shou J, Naama H, Cech A, Gallagher H y Daly

JM: Inhibition of nitric oxide synthesis is detrimental during

endotoxemia. Arch Surg, 1994, 129:142-147.

65. Liu P, Yin K, Yue G y Wong PY: Role of nitric oxide in hepa-

tic ischemia-reperfusion with endotoxemia. J Inflamm, 1995,


66. Liu P, Hock CE, Nagele R y Wong PY: Formation of nitric

oxide, superoxide, and peroxynitrite in myocardial ischemia-

reperfusion injury in rats. Am J Physiol, 1997, 272:2327-2336.

67. Moncada S, Palmer RMJ y Higgs EA: Nitric oxide: physio-

logy, pathophysiology, and pharmacology. Pharmacol Rev,

1991, 43:109-141.

68. Kuo PC, Schroeder RA y Loscalzo J: Nitric oxide andaceta-

minophen-mediated oxidative injury: modulation of interleu-

kin-1-induced nitric oxide synthesis in cultured rat hepatocy-

tes. J Pharmacol Exp Ther, 1997, 282:1072-1083.

69. Smail N, Catania RA, Wang P, Cioffi WG, Bland KI y

Chaudry IH: Gut and liver. The organs responsible for increa-

sed nitric oxide production after trauma-hemorrhage and re-

suscitation. Arch Surg, 1998, 133:399-405.

70. Mauriz JL, Matilla B, Culebras JM, González P y González-

Gallego J: Dietery glycine inhibits activation of nuclear factor

kappa B and prevents liver injury in hemorrhagic shock in the

rat. Free Rad Biol Med, 2001, 31:1236-1244.

71. Stark ME y Szurszewski JH: Role of nitric oxide in gastroin-

testinal and hepatic function and disease. Gastroenterology,

1992, 103:1928-1949.

72. Kim SJ, Glick A, Sporn MB y Roberts AB: Characterization

of the promoter region of the human transforming growth fac-

tor-b1 gene. J Biol Chem, 1989, 264:402-408.

73. Sen R y Baltimore D: Multiple nuclear factors interact with

the immunoglobulin enhancer sequences. Cell, 1986, 46:705-


74. Román J: Contribución de los factores de transcripción NF-

êB y AP-1 en la patogenia de la fibrosis hepatica y en la hepa-

topatía alcohólica. Tesis Doctoral. Facultad de Medicina, Uni-

versidad de Barcelona, 2000.

75. Hayashi T, Sekine T y Okamoto T: Identification of a new se-

rine kinase that activates NF kappa B by direct phosphoryla-

tion. J Biol Chem, 1993, 15:26790-26795.


Grupo Medico Dr. Zurita




Calz. de la Viga 1593

Col. Unidad Modelo

(Entre Río Churubusco

y Ote. 160)

C.P. 09089

Ciudad de México




Av. de la Fuentes

Col. Jardínes del Pedregal

(Entre Agua y Lluvia)

C.P. 01900

Ciudad de México



Teléfonos: (55) 55-81-0639

Fax:            (55) 56-70-9179


lun-vie :

10:00 am - 05:00 pm

sáb :

10:00 am - 03:00 pm

Versión para imprimir Versión para imprimir | Mapa del sitio Recomendar esta página Recomendar esta página
© doctorzurita Retorno 102 de Ote. 160 Edif 50-101 09089 Distrito Federal, México



Cómo llegar